{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T18:58:58Z","timestamp":1778007538750,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gene"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.gene.2012.03.067","type":"journal-article","created":{"date-parts":[[2012,4,9]],"date-time":"2012-04-09T20:58:46Z","timestamp":1334005126000},"page":"188-192","source":"Crossref","is-referenced-by-count":17,"title":["Paraoxonase 1 polymorphisms L55M and Q192R were not risk factors for Parkinson's disease: A HuGE review and meta-analysis"],"prefix":"10.1016","volume":"501","author":[{"given":"Ying-Li","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dian-Wu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Bao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2012.03.067_bb0005","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000022868","article-title":"Gln\u2013>Arg 191 polymorphism of paraoxonase and Parkinson's disease","volume":"49","author":"Akhmedova","year":"1999","journal-title":"Hum. Hered."},{"key":"10.1016\/j.gene.2012.03.067_bb0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0022-510X(01)00439-7","article-title":"Paraoxonase 1 Met\u2013Leu 54 polymorphism is associated with Parkinson's disease","volume":"184","author":"Akhmedova","year":"2001","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.gene.2012.03.067_bb0015","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/mds.10172","article-title":"Further evidence for an association of the paraoxonase 1 (PON1) Met-54 allele with Parkinson's disease","volume":"17","author":"Carmine","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.gene.2012.03.067_bb0020","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.neurobiolaging.2007.05.021","article-title":"Association study of the paraoxonase 1 gene with the risk of developing Alzheimer's disease","volume":"30","author":"Chapuis","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.gene.2012.03.067_bb0025","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neulet.2004.05.108","article-title":"Paraoxonase 1 (PON1) gene polymorphisms and Parkinson's disease in a Finnish population","volume":"367","author":"Clarimon","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.gene.2012.03.067_bb0030","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/GIM.0b013e3181ee81c6","article-title":"Paraoxonase 1 polymorphisms and ischemic stroke risk: a systematic review and meta-analysis","volume":"12","author":"Dahabreh","year":"2010","journal-title":"Genet. Med."},{"key":"10.1016\/j.gene.2012.03.067_bb0035","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/ng1196-334","article-title":"The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin","volume":"14","author":"Davies","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2012.03.067_bb0040","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/oem.2006.032078","article-title":"Gene\u2013environment interactions in parkinsonism and Parkinson's disease: the Geoparkinson study","volume":"64","author":"Dick","year":"2007","journal-title":"Occup. Environ. Med."},{"key":"10.1016\/j.gene.2012.03.067_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10528-010-9376-6","article-title":"PON1 55 and 192 gene polymorphisms in type 2 diabetes mellitus patients in a Turkish population","volume":"49","author":"Ergun","year":"2011","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.gene.2012.03.067_bb0050","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/bdra.20727","article-title":"Paraoxonase 1 polymorphisms and haplotypes and the risk for having offspring affected with spina bifida in Southeast Mexico","volume":"88","author":"Gonzalez-Herrera","year":"2010","journal-title":"Birth Defects Res. A Clin. Mol. Teratol."},{"key":"10.1016\/j.gene.2012.03.067_bb0055","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4238\/vol9-3gmr893","article-title":"The L55M polymorphism of paraoxonase-1 is a risk factor for rheumatoid arthritis","volume":"9","author":"Hashemi","year":"2010","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.gene.2012.03.067_bb0060","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature01782","article-title":"The DNA sequence of human chromosome 7","volume":"424","author":"Hillier","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.gene.2012.03.067_bb0065","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/jnnp.74.4.546","article-title":"Paraoxonase 1 promoter and coding region polymorphisms in Parkinson's disease","volume":"74","author":"Kelada","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.gene.2012.03.067_bb0070","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0006-8993(98)00586-1","article-title":"Genetic polymorphism of paraoxonase 1 (PON1) and susceptibility to Parkinson's disease","volume":"806","author":"Kondo","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.gene.2012.03.067_bb0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11745-008-3251-9","article-title":"Alterations in the high density lipoprotein phenotype and HDL-associated enzymes in subjects with metabolic syndrome","volume":"44","author":"Lagos","year":"2009","journal-title":"Lipids"},{"key":"10.1016\/j.gene.2012.03.067_bb0080","doi-asserted-by":"crossref","first-page":"820","DOI":"10.7326\/0003-4819-127-9-199711010-00008","article-title":"Quantitative synthesis in systematic reviews","volume":"127","author":"Lau","year":"1997","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.gene.2012.03.067_bb0085","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00008571-200012000-00002","article-title":"Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds","volume":"10","author":"Li","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.gene.2012.03.067_bb0090","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0378-4274(95)80006-Y","article-title":"Paraoxonase protects against chlorpyrifos toxicity in mice","volume":"76","author":"Li","year":"1995","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.gene.2012.03.067_bb0095","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1046\/j.1365-2362.2000.00580.x","article-title":"Paraoxonase activity in two healthy populations with differing rates of coronary heart disease","volume":"30","author":"MacKness","year":"2000","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.gene.2012.03.067_bb0100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/EDE.0b013e3181c15ec6","article-title":"Paraoxonase 1, agricultural organophosphate exposure, and Parkinson disease","volume":"21","author":"Manthripragada","year":"2010","journal-title":"Epidemiology"},{"key":"10.1016\/j.gene.2012.03.067_bb0105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0378-1119(98)00193-0","article-title":"Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence","volume":"213","author":"Mochizuki","year":"1998","journal-title":"Gene"},{"key":"10.1016\/j.gene.2012.03.067_bb0110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ana.10079","article-title":"Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms","volume":"51","author":"Momose","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.gene.2012.03.067_bb0115","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000045161","article-title":"The serum paraoxonase activity in patients with chronic renal failure and hyperlipidemia","volume":"80","author":"Paragh","year":"1998","journal-title":"Nephron"},{"key":"10.1016\/j.gene.2012.03.067_bb0120","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1353\/hub.2003.0049","article-title":"New data on the world distribution of paraoxonase (PON1 Gln 192\u2013>Arg) gene frequencies","volume":"75","author":"Scacchi","year":"2003","journal-title":"Hum. Biol."},{"key":"10.1016\/j.gene.2012.03.067_bb0125","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1210\/jc.2003-030648","article-title":"Antioxidant paraoxonase 1 activity in the metabolic syndrome","volume":"88","author":"Senti","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.gene.2012.03.067_bb0130","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/28406","article-title":"Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis","volume":"394","author":"Shih","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.gene.2012.03.067_bb0135","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1179\/135100008X308911","article-title":"Assessment of paraoxonase activities in patients with knee osteoarthritis","volume":"13","author":"Soran","year":"2008","journal-title":"Redox Rep."},{"key":"10.1016\/j.gene.2012.03.067_bb0140","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1212\/WNL.55.4.533","article-title":"Variability and validity of polymorphism association studies in Parkinson's disease","volume":"55","author":"Tan","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.gene.2012.03.067_bb0145","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.freeradbiomed.2008.11.019","article-title":"Human carotid atherosclerotic plaque increases oxidative state of macrophages and low-density lipoproteins, whereas paraoxonase 1 (PON1) decreases such atherogenic effects","volume":"46","author":"Tavori","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.gene.2012.03.067_bb0150","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s007020070046","article-title":"Paraoxonase polymorphisms, pesticide exposure and Parkinson's disease in a Caucasian population","volume":"107","author":"Taylor","year":"2000","journal-title":"J. Neural Transm."},{"issue":"Suppl. 3","key":"10.1016\/j.gene.2012.03.067_bb0155","first-page":"III40","article-title":"Toward identification of susceptibility genes for sporadic Parkinson's disease","volume":"250","author":"Toda","year":"2003","journal-title":"J. Neurol."},{"key":"10.1016\/j.gene.2012.03.067_bb0160","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/1531-8257(200011)15:6<1265::AID-MDS1034>3.0.CO;2-0","article-title":"No association between paraoxonase 1 (PON1) gene polymorphisms and susceptibility to Parkinson's disease in a Chinese population","volume":"15","author":"Wang","year":"2000","journal-title":"Mov. Disord."},{"key":"10.1016\/j.gene.2012.03.067_bb0165","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.neurobiolaging.2010.08.010","article-title":"Paraoxonase-1 polymorphisms in Alzheimer's disease, Parkinson's disease, and AD\u2013PD spectrum diseases","volume":"33","author":"Wingo","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.gene.2012.03.067_bb0170","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s11033-009-9514-6","article-title":"Sequence identification, chromosomal mapping and tissue specific expression of the porcine paraoxonase 1 (PON1) gene","volume":"37","author":"Xie","year":"2010","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.gene.2012.03.067_bb0175","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.clinbiochem.2008.02.010","article-title":"Paraoxonase and arylesterase activities in untreated dipper and non-dipper hypertensive patients","volume":"41","author":"Yildiz","year":"2008","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.gene.2012.03.067_bb0180","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s10038-004-0176-x","article-title":"Association of paraoxonase 1 gene polymorphisms with risk of Parkinson's disease: a meta-analysis","volume":"49","author":"Zintzaras","year":"2004","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.gene.2012.03.067_bb0185","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/gepi.20048","article-title":"Heterogeneity testing in meta-analysis of genome searches","volume":"28","author":"Zintzaras","year":"2005","journal-title":"Genet. Epidemiol."},{"key":"10.1016\/j.gene.2012.03.067_bb0190","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jclinepi.2007.12.011","article-title":"Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches","volume":"61","author":"Zintzaras","year":"2008","journal-title":"J. Clin. Epidemiol."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111912003800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111912003800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,24]],"date-time":"2018-11-24T06:59:14Z","timestamp":1543042754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111912003800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0378111912003800"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2012.03.067","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}